Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Matuschek

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2015
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trialsWilfried Budach, Edwin Bölke, Kai Kammers, et al.
Wiener Klinische Wochenschrift|March 10, 2010
Pyoderma gangrenosumNorman-Philipp Hoff, Edwin Bölke, Christiane Matuschek, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
PSA after incidental irradiation of the nonmalignant prostate: long-term changesStephan Gripp, Daniel Roos, Michael Rudoy, et al.
Radiation Oncology (London, England)|June 18, 2010
Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysisFranziska Eckert, Christiane Matuschek, Arndt-Christian Mueller, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2011
Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trialWilfried Budach, Edwin Bölke, Rainer Fietkau, et al.
Radiation Oncology (London, England)|June 13, 2019
Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysisJan Haussmann, Wilfried Budach, Balint Tamaskovics, et al.
Cancers|September 9, 2023
Whole Breast Irradiation in Comparison to Endocrine Therapy in Early Stage Breast Cancer-A Direct and Network Meta-Analysis of Published Randomized TrialsJan Haussmann, Wilfried Budach, Stefanie Corradini, et al.
Cancer Gene Therapy|April 30, 2003
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cellsChangxian Shen, Andreas Buck, Bülent Polat, et al.
Wiener Klinische Wochenschrift|January 6, 2009
Soft tissue sarcomaMatthias Peiper, Peter Arne Gerber, Rainer Engers, et al.
Radiation Oncology (London, England)|November 3, 2023
Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trialsJan Haussmann, Wilfried Budach, Stefanie Corradini, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 22, 2015
Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trialsWilfried Budach, Edwin Bölke, Kai Kammers, et al.
Wiener Klinische Wochenschrift|March 10, 2010
Pyoderma gangrenosumNorman-Philipp Hoff, Edwin Bölke, Christiane Matuschek, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 19, 2008
PSA after incidental irradiation of the nonmalignant prostate: long-term changesStephan Gripp, Daniel Roos, Michael Rudoy, et al.
Radiation Oncology (London, England)|June 18, 2010
Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysisFranziska Eckert, Christiane Matuschek, Arndt-Christian Mueller, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2011
Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trialWilfried Budach, Edwin Bölke, Rainer Fietkau, et al.
Radiation Oncology (London, England)|June 13, 2019
Which target volume should be considered when irradiating the regional nodes in breast cancer? Results of a network-meta-analysisJan Haussmann, Wilfried Budach, Balint Tamaskovics, et al.
Cancers|September 9, 2023
Whole Breast Irradiation in Comparison to Endocrine Therapy in Early Stage Breast Cancer-A Direct and Network Meta-Analysis of Published Randomized TrialsJan Haussmann, Wilfried Budach, Stefanie Corradini, et al.
Cancer Gene Therapy|April 30, 2003
Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cellsChangxian Shen, Andreas Buck, Bülent Polat, et al.
Wiener Klinische Wochenschrift|January 6, 2009
Soft tissue sarcomaMatthias Peiper, Peter Arne Gerber, Rainer Engers, et al.
Radiation Oncology (London, England)|November 3, 2023
Comparison of adverse events in partial- or whole breast radiotherapy: investigation of cosmesis, toxicities and quality of life in a meta-analysis of randomized trialsJan Haussmann, Wilfried Budach, Stefanie Corradini, et al.
Pageof 10